Ad Partners II, LLC
Ad Partners II, LLC was paid $3.81M by Medicaid between Jan 2018 and Nov 2024, across 49 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 83% of everything it billed.
ANCHORAGE, AK 99504
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Alaska
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,139 | $553K | |
| 2019 | 35,264 | $479K | |
| 2020 | 40,469 | $476K | |
| 2021 | 39,017 | $521K | |
| 2022 | 40,804 | $548K | |
| 2023 | 33,680 | $600K | |
| 2024incomplete | 40,604 | $630K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 83% | 60,811 | 4,690 | $3.14M |
| 90945 | 14% | 34,692 | 984 | $519K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 2.5% | 5,395 | 3,097 | $94K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | <1% | 6,165 | 688 | $26K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 11,596 | 2,593 | $10K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 705 | 60 | $7K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | <1% | 543 | 212 | $7K |
| A4657 | Syringe, with or without needle, each | <1% | 27,850 | 4,436 | $973.65 |
| 83970 | <1% | 4,452 | 4,110 | $34.84 | |
| 84466 | <1% | 4,614 | 4,341 | $11.01 | |
| 87340 | <1% | 4,564 | 4,166 | $9.12 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,568 | 5,146 | $6.75 |
37 more codes
| 84520 | <1% | 11,277 | $6.30 | |
| 80051 | <1% | 4,911 | $6.23 | |
| 83540 | <1% | 5,501 | $5.72 | |
| 82565 | <1% | 5,635 | $4.31 | |
| 85014 | <1% | 6,460 | $4.22 | |
| 84100 | <1% | 6,507 | $4.21 | |
| 85018 | <1% | 6,793 | $4.14 | |
| 84075 | <1% | 5,646 | $4.13 | |
| 82310 | <1% | 6,377 | $4.10 | |
| 82040 | <1% | 5,932 | $4.02 | |
| 84155 | <1% | 5,441 | $2.96 | |
| 82728 | 0% | 1,974 | $0.00 | |
| J2501 | Injection, paricalcitol, 1 mcg | 0% | 9,081 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 0% | 10,088 | $0.00 |
| 86706 | 0% | 454 | $0.00 | |
| 82746 | 0% | 330 | $0.00 | |
| 82435 | 0% | 594 | $0.00 | |
| 83735 | 0% | 1,502 | $0.00 | |
| 83550 | 0% | 816 | $0.00 | |
| J0606 | Injection, etelcalcetide, 0.1 mg | 0% | 1,015 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 326 | $0.00 |
| 82607 | 0% | 330 | $0.00 | |
| 84132 | 0% | 674 | $0.00 | |
| 90674 | 0% | 124 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 445 | $0.00 |
| 90688 | 0% | 32 | $0.00 | |
| 90694 | 0% | 29 | $0.00 | |
| 90686 | 0% | 63 | $0.00 | |
| 0001A | 0% | 15 | $0.00 | |
| 82374 | 0% | 1,590 | $0.00 | |
| 84295 | 0% | 594 | $0.00 | |
| 82108 | 0% | 328 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 62 | $0.00 |
| 90653 | 0% | 14 | $0.00 | |
| 0002A | 0% | 13 | $0.00 | |
| 91300 | 0% | 24 | $0.00 | |
| 90661 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.